This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: The Innovations of Suzuka Iemoto
Introduction
Suzuka Iemoto is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aqueous liquid compositions. With a total of 2 patents to his name, Iemoto's work has garnered attention for its innovative approach to preserving the efficacy of medicinal compositions.
Latest Patents
Iemoto's latest patents include an aqueous liquid bromfenac composition that demonstrates preservative efficacy. This composition contains bromfenac or a salt thereof, along with benzalkonium chloride. The unique characteristic of this formulation is that the concentration of benzalkonium chloride is higher than 0.0005% and lower than 0.005%. This innovation aims to enhance the stability and effectiveness of the bromfenac composition.
Career Highlights
Iemoto is currently associated with Senju Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work is instrumental in developing formulations that improve patient outcomes and ensure the longevity of medicinal products.
Collaborations
Iemoto collaborates with talented individuals in his field, including Shuichi Nishihata and Wakiko Asayama. Their combined expertise contributes to the advancement of pharmaceutical technologies and the development of effective treatments.
Conclusion
Suzuka Iemoto's contributions to the pharmaceutical industry through his innovative patents highlight the importance of research and development in creating effective medical solutions. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile